Healthcare provider profile · identity verified

Ginger Lea Smith, FNP

Nurse Practitioner · DENVER, CO · NPI 1326281528

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	396	69
Levothyroxine Sodium	Levothyroxine Sodium	316	65
Omeprazole	Omeprazole	276	62
Gabapentin	Gabapentin	270	37
Lisinopril	Lisinopril	239	58
Rosuvastatin Calcium	Rosuvastatin Calcium	232	51
Famotidine	Famotidine	220	36
Metformin Hcl	Metformin Hcl	184	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	156	22
Trazodone Hcl	Trazodone Hcl	149	32
Losartan Potassium	Losartan Potassium	143	41
Albuterol Sulfate Hfa	Albuterol Sulfate	128	39
Amlodipine Besylate	Amlodipine Besylate	126	32
Tramadol Hcl	Tramadol Hcl	110	19
Fluticasone Propionate	Fluticasone Propionate	107	36
Hydrochlorothiazide	Hydrochlorothiazide	100	23
Oxycodone Hcl	Oxycodone Hcl	95	14
Metoprolol Succinate	Metoprolol Succinate	93	24
Tamsulosin Hcl	Tamsulosin Hcl	87	18
Tizanidine Hcl	Tizanidine Hcl	85	20
Alendronate Sodium	Alendronate Sodium	84	14
Metformin Hcl Er	Metformin Hcl	83	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	82	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	81	12
Sertraline Hcl	Sertraline Hcl	77	16
Paroxetine Hcl	Paroxetine Hcl	76	12
Potassium Chloride	Potassium Chloride	71	14
Oxybutynin Chloride Er	Oxybutynin Chloride	70	15
Pantoprazole Sodium	Pantoprazole Sodium	68	15
Duloxetine Hcl	Duloxetine Hcl	59	14
Hydroxyzine Hcl	Hydroxyzine Hcl	57	13
Symbicort	Budesonide/Formoterol Fumarate	56	11
Escitalopram Oxalate	Escitalopram Oxalate	55	11
Ezetimibe	Ezetimibe	54	17
Glipizide Er	Glipizide	53	11
Simvastatin	Simvastatin	52	16
Furosemide	Furosemide	51	15
Carvedilol	Carvedilol	50	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	12
Morphine Sulfate Er	Morphine Sulfate	48	suppressed
Ibuprofen	Ibuprofen	46	13
Montelukast Sodium	Montelukast Sodium	46	12
Buspirone Hcl	Buspirone Hcl	45	11
Ventolin Hfa	Albuterol Sulfate	45	13
Prednisone	Prednisone	44	25
Fenofibrate	Fenofibrate	43	suppressed
Meloxicam	Meloxicam	43	suppressed
Ondansetron Odt	Ondansetron	42	suppressed
Pregabalin	Pregabalin	42	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	40	suppressed
Levetiracetam	Levetiracetam	39	suppressed
Acyclovir	Acyclovir	37	13
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Atenolol	Atenolol	34	suppressed
Lovastatin	Lovastatin	34	suppressed
Baclofen	Baclofen	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Spironolactone	Spironolactone	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Eliquis	Apixaban	28	suppressed
Jardiance	Empagliflozin	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Allopurinol	Allopurinol	26	suppressed
Divalproex Sodium	Divalproex Sodium	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Glipizide	Glipizide	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Methocarbamol	Methocarbamol	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	13
Januvia	Sitagliptin Phosphate	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Estradiol	Estradiol	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Naproxen	Naproxen	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	11
Warfarin Sodium	Warfarin Sodium	18	suppressed
Diazepam	Diazepam	17	suppressed
Topiramate	Topiramate	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Finasteride	Finasteride	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Azithromycin	Azithromycin	15	15
Clonidine Hcl	Clonidine Hcl	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Clonidine	Clonidine	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Ozempic	Semaglutide	14	suppressed
Tegretol Xr	Carbamazepine	14	suppressed
Azathioprine	Azathioprine	13	suppressed
Griseofulvin Ultramicrosize	Griseofulvin Ultramicrosize	13	suppressed
Restasis	Cyclosporine	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Fluconazole	Fluconazole	12	11
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Movantik	Naloxegol Oxalate	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Naloxone Hcl	Naloxone Hcl	11	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Zaleplon	Zaleplon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error